BCBahar Demir Cevizlidere

Bahar Demir Cevizlidere

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bahar Demir Cevizlidere has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of a High‐Sensitivity Electrochemical Biosensor for Domoic Acid and Its Cellular Impact on Human Stem and Neuron‐Like Cells

    by Emilia Qomi Ekenel, Yucel Koc, Burcugul Altug, Merve Nur Soykan, Bahar Demir Cevizlidere, Sibel Gunes Bagis, Onur Uysal, Tugba Semerci Sevimli, Murat Sevimli, Ayla Eker Sariboyaci, et al.

    Domoic acid (DA) is an important environmental neurotoxin produced by certain types of marine algae and can accumulate in seafood such as anchovies, sardines, and mussels, which are considered healthy and widely consumed globally. One of the most important issues to consider is taking necessary measures to prevent water and marine pollution and conducting proper safety controls before consuming seafood. This study aimed to develop a high‐sensitivity electrochemical biosensor system for detecting DA in seafood, aiding marine pollution monitoring. Additionally, the cytotoxicity of DA at the highest Food & Drug Administration (FDA)‐permitted concentration and the concentrations determined in this study was examined on human cells. Gene expression related to cytotoxic response, DNA repair, and neurotoxicity was analyzed using amniotic fluid‐derived mesenchymal stem cells (hAF‐MSCs) and the human neuroblastoma cell line (SH‐SY5Y) as neuron‐like cell models. DA did not significantly affect the viability of hAF‐MSCs or SH‐SY5Y cells at 48‐h exposure but slightly reduced viability at 100 μg/mL compared to the control group. DA activated the glutamate receptor in hAF‐MSCs but not in SH‐SY5Y cells. It also reduced DNA repair capacity in hAF‐MSCs, though effects on viability and proliferation likely did not manifest within 48 h. There was no change in gene expression at 75 ng/mL of DA, which indicated the tolerable daily intake set by the FDA. The SH‐SY5Y cells exhibited resistance against DA, indicating enhanced their DNA repair to prevent themselves against apoptosis and cell death. It is also supported by the upregulation of DNA repair‐related genes and the membrane transporter gene ABCG2.

  • Open Access

    A comparative study of synthetic and natural hydroxyapatite reinforcements in biodegradable magnesium–silver composites

    by Mustafa Özgür Öteyaka, Neşe Öztürk Körpe, Kerem Aybar, Bahar Demir Cevizlidere, Nadiye Boncukçu, Dilay Karacaoğlu

    Biodegradable magnesium composites are attractive materials for bone implant applications. This study compares synthetic (HAS) and natural (HAN) hydroxyapatite reinforcements in Mg1Ag composites regarding mechanical and corrosion performance. Microstructural analysis showed that reinforcements were distributed along grain boundaries as secondary phases. The addition of 10 wt-% HAS increased the hardness by 23.6%. Higher compressive strength was achieved with 5-10 wt-% HAN, reaching 187 MPa (65% improvement over Mg1Ag), while 5 wt-% HAS improved strength by ∼ 9% and enhancing ductility. Corrosion results indicated 15 wt-% HAS and HAN composites exhibited the most anodic E ocp (+36 mV and +31 mV vs. Mg1Ag). Potentiodynamic analysis identified 15 wt-% HAS as the most corrosion resistant ( E corr : − 1210 mV, i corr : 127 μA), whereas HAN composites showed higher i corr (>304 μA) than the Mg1Ag. Finally, MTT assays confirmed all composites are cytocompatible with Saos-2 cells, showing no significant cytotoxic effects.

  • Open Access

    Liver-on-a-Chip (LoC) Models: Case Studies of Academic Platforms and Commercial Products

    by Zineb Benzait, Özlem Tomsuk, Aliakbar Ebrahimi, Hamed Ghorbanpoor, Ceren Özel, Reza Didarian, Bahar Demir Cevizlidere, Murat Kaya, Tamer Gur, Nigar Gasimzade, et al.

    Pharmaceutical companies place significant importance on the liver due to its crucial role in numerous biochemical processes, specifically in drug metabolism. This focus has led to significant progress in liver-on-a-chip (LoC) technology, which has proven useful not only in drug development but also in more advanced applications. As a result, elaboration and incorporation of advanced LoC models into preclinical workflows have great potential to decrease R&D expenses and reduce or even replace animal testing, while improving the safety and efficacy of new therapies. To explore this potential, the present review provides an overview of recent academic and commercial LoC models, examines their different designs and cellular compositions, and evaluates the advantages and disadvantages of their complexity. A systematic comparison of these models is then performed, along with a discussion of their current challenges and future perspectives. Ultimately, we hope this review will assist scientists and industry professionals in selecting optimal models and in contributing to future advancements in LoC technology.


  • The Effect of Wharton s Jelly Mesenchymal Stem Cell Application on Haematological Parameters in Cows with Subclinical Mastitis

    by Ayşegül BULUT, Merve Nur Soykan, Fatih Aladağ, Ayla Eker Sariboyaci, Durmuş HATİPOĞLU, Onur Uysal, Sibel Güneş Bağiş, Süleyman Gökhan Kara, Bahar Demi̇r Cevi̇zLi̇dEre, Burcugül Altuğ, et al.

    This study aimed to investigate the effect of intramammary Wharton's Jelly mesenchymal stem cell (WJ-MSC) administration on haematological parameters in cows with subclinical mastitis. In the study, 20 Holstein cows kept under equal care and feeding conditions during the same lactation period were used. The California Mastitis Test (CMT) was applied to identify animals with subclinical mastitis. Animals were divided into 4 groups: control (n=4, 3 ml DMEM solution, intramammary, days 2 and 9), Wharton's Jelly mesenchymal stem cells (n=4, WJ-MSCs, 2.5 x 107 WJ-MSCs, intramammary, days 2 and 9), subclinical mastitis (n=6, SM, parenteral antibiotic treatment, days 2 and 9), and SM+WJ-MSCs (n=6, 2.5 x 107 WJ-MSCs, days 2 and 9). On the 1st and 30th days of the study, blood samples were taken directly from the jugular vein under aseptic conditions into EDTA tubes containing anticoagulant for the evaluation of haematological parameters. Parameters related to infection and inflammation were evaluated in blood count analyses. It was found that the reference ranges for the parameters leukocyte (WBC), erythrocyte (RBC), haemoglobin (HGB), haematocrit (HCT), platelet (PLT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), neutrophil percentage Neu (%), and lymphocyte percentage (Lym%) varied. The WBC value, which was above the reference range on day 1, was measured within the reference range on day 30. It was found that the Neu% value, which was above the reference value in the Day 1 measurement, and the Lym% value, which was below the reference value, were within the reference values in the post-treatment measurement. The results obtained indicate that the application of WJ-MSCs has no negative effect on haematological parameters and may even play a balancing role in the inflammatory response for some parameters due to its immunomodulatory effects.

  • Therapeutic potential of human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) for treating clinical and subclinical mastitis in dairy cows

    by Durmus Hatipoglu, Mehmet Burak Ates, Ayla Eker Sariboyaci, Onur Uysal, Merve Nur Soykan, Burcugul Altug, Bahar Demir Cevizlidere, Fulya Buge Ergen, Aynaz Ghorbani, Fatih Aladag

  • Open Access

    Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells

    by Bahar Demir Cevizlidere, Onur Uysal, Huseyin Avci, Sibel Gunes Bagis, Tugba Semerci Sevimli, Murat Dincer, Emilia Qomi Ekenel, Suleyman Gokhan Kara, Merve Nur Soykan, Ayla Eker Sariboyaci

    Due to their high expression profile of multi‐drug resistance genes, cancer stem cells (CSCs) are the main source of drug resistance. The aim of this study was to establish a gemcitabine‐hydrochloride‐resistant (rt) human non‐small cell lung cancer (hNSCLC) cell line and their CSC line to be used as disease models in various cancer studies. In the first phase of study, a gemcitabine hydrochloride‐rt hNSCLC line cells was produced by making them rt through periodic exposure to gemcitabine hydrochloride. This acquired gemcitabine‐hydrochloride‐rt hNSCLC cell line was characterized for resistance. Subsequently, a CSC population with a CD326 + CD133 + CD44+ phenotypes was immunoselectively isolated from gemcitabine hydrochloride‐rt hNSCLCs purified from a single cell by colony forming technology. This rt CSC line was characterized for both resistance and stemness. Rt and non‐rt CSCs were analyzed and compared with each other in terms of immunophenotyping the expression profiles of ALDH1, CD90, ABCG2, CD44 and MDR1, which are CSC specific markers, of demonstrating mitotic capacity with growth curve analysis and of their ability to form tumor spheroids in three different 3D cultures. The results of this study demonstrated for the first time the successful generation of both gemcitabine‐hydrochloride‐rt hNSCLC cells and CSCs derived from gemcitabine‐hydrochloride‐rt hNSCLC cells. It was also shown that isolated and characterized rt CSCs could proliferate and form tumor spheres in vitro using three different 3D in vitro techniques. It was shown that the cell surface markers CD326, CD133 and CD44 can serve as an antibody panel for CSCs.


  • Open Access

    Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study

    by Tuğba Semerci Sevimli, Aynaz Ghorbani, Bahar Demir Cevizlidere, Burcugül Altuğ, Murat Sevimli

    DNA double-strand break (DSB) repair genes interact with tumor stemness- and resistance-associated processes in cancer stem cells (CSCs). Therefore, targeting DNA DSB genes in cancer treatment is important for the CSC phenotype. Although the anti-cancer effect of boric acid (BA) has been studied, its effect on DNA DSB is unclear. Moreover, no studies investigate BA’s effects on DNA DSB of lung cancer stem cells (LC-SCs). To fill the gap, we aimed to assess the effects of BA on A549 cancer stem cells. CSCs were isolated from human non-small cell lung cancer cells (A549) and characterized by flow cytometry. Different concentrations of BA (at doses ranging from 1 to 100 mM) were applied to cancer stem cells. Cytotoxic activities were determined using the cell viability assay (MTT assay) at 24 and 48 h. Expression levels of DNA DSB genes that BRCA1, BRCA2, RAD51, KU70/80, ATM, and XRCC4 were evaluated by RT-qPCR. Additionally, immunofluorescence staining analysis was exploited for caspase-3 and E-cadherin. ATM expression increased significantly (p < 0.001). No significant change was observed in the expression of other genes. Moreover, BA up-regulated caspase-3 and E-cadherin expression. Consequently, we can say that BA affects DNA DSB and the apoptotic abilities of LC-SCs. Graphical Abstract


  • Boric Acid Alters the Expression of DNA Double Break Repair Genes in MCF-7-Derived Breast Cancer Stem Cells

    by Tuğba Semerci Sevimli, Aynaz Ghorbani, Fidan Gakhiyeva, Bahar Demir Cevizlidere, Murat Sevimli

    Breast cancer pathology ranks second in mortality among women worldwide due to the resistance of cancer stem cells in tumor tissue to radiotherapy and chemotherapy and their effective DNA damage response system (DDR). Targeting the expression of DNA double-strand break (DSB) repair genes in breast cancer stem cells (BC-SCs) is essential for facilitating their elimination with conventional therapies. This study aims to investigate the effects of boric acid (BA) on the expression of DNA DSB repair genes in BC-SCs, which has not been studied in the literature before. BS-SCs were isolated by the MACS method and characterized by flow cytometry. The effects of BA on BC-SCs’ DNA DSB repair genes were deciphered by cell viability assay, inverted microscopy, and RT-qPCR. While the expression of the BRCA1 and BRCA2 was upregulated, the expression of the ATM (p < 0.001), RAD51 (p < 0.001), and KU70 (p < 0.001) was downregulated in dose-treated BC-SCs (p < 0.001) to the qPCR results. Consequently, BA affects some of the DNA DSB repair genes of breast cancer stem cells. Findings from this study could provide new insights into the potential therapeutic application of BA in BC-SC elimination and cancer intervention. Graphical Abstract